original ) (raw )Immune responses against Mycobacterium tuberculosis targets associated to latent and active Tuberculosis infection
Toshi Nagata
2014
View PDFchevron_right
Tuberculosis: looking beyond BCG vaccines
Raja'a Al-Attiyah
Journal of postgraduate medicine
View PDFchevron_right
Immunology of tuberculosis
Laurent Nicod
Swiss medical weekly: official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology
View PDFchevron_right
The immunology of tuberculosis: From bench to bedside
Stephan Schwander
Respirology, 2010
View PDFchevron_right
Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis
Raja'a Al-Attiyah
Microbiology and Immunology, 2011
View PDFchevron_right
Fighting Tuberculosis: In Search of a BCG Replacement
Anna Goncharenko
Microorganisms
View PDFchevron_right
Vaccines against tuberculosis: moving forward with new concepts
Radha Gopal
Expert Review of Vaccines, 2013
View PDFchevron_right
Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis
Nada Madi , Harald Wiker
Fems Immunology and Medical Microbiology, 2006
View PDFchevron_right
Vaccine Approaches to Prevent Tuberculosis
T. Mustafa , Anne Dyrhol-Riise
Scandinavian Journal of Immunology, 2006
View PDFchevron_right
M. tuberculosis: immunology and vaccination
Graham A W Rook
European Respiratory Journal, 2001
View PDFchevron_right
Characterization of human cellular immune responses toMycobacterium tuberculosisproteins encoded by genes predicted in RD15 genomic region that is absent inMycobacterium bovisBCG
Raja'a Al-Attiyah
FEMS Immunology & Medical Microbiology, 2010
View PDFchevron_right
Immunodominant Mycobacterium tuberculosis Protein Rv1507A Elicits Th1 Response and Modulates Host Macrophage Effector Functions
Javeed Ahmad
Frontiers in Immunology, 2020
View PDFchevron_right
Novel M tuberculosis Antigen-Specific T-Cells Are Early Markers of Infection and Disease Progression
Ahmet Soysal
PLOS One, 2011
View PDFchevron_right
Differential Live Mycobacterium tuberculosis-, M. bovis BCG, Recombinant ESAT6-, and Culture Filtrate Protein 10Induced Immunity in Tuberculosis
Bushra Ashraf
Clinical and Vaccine Immunology, 2009
View PDFchevron_right
Novel vaccine strategies against tuberculosis: a road less travelled
Supriya Pokkali
View PDFchevron_right
Targeting innate immunity for tuberculosis vaccination
Markus Maeurer
Journal of Clinical Investigation, 2019
View PDFchevron_right
A genomic analysis of Mycobacterium immunogenum strain CD11_6 and its potential role in the activation of T cells against Mycobacterium tuberculosis
ATUL CHANDER
BMC Microbiology, 2019
View PDFchevron_right
Unique Characteristic Features of Mycobacterium Tuberculosis in Relation to Immune System
Laxman S Meena
American Journal of Immunology, 2011
View PDFchevron_right
“The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design” – Meeting report
Cesar Boggiano
Vaccine, 2017
View PDFchevron_right
Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population
hammad mehmood
Journal of Immunological Methods, 2002
View PDFchevron_right
Expert Opinion on Biological Therapy An update on vaccines for tuberculosis – there is more to it than just waning of BCG efficacy with time
K. Huygen
View PDFchevron_right
Screening and Assessing 11 Mycobacterium tuberculosis Proteins as Potential Serodiagnostical Markers for Discriminating TB Patients from BCG Vaccinees
Linlin Pan
Genomics, Proteomics & Bioinformatics, 2009
View PDFchevron_right
New potential biomarkers to assess efficacy of protection afforded by vaccine candidates against tuberculosis
Mario Alberto Flores-Valdez
Clinical Microbiology and Infection, 2019
View PDFchevron_right
Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis
Sandra Arend , Tom h.m. Ottenhoff
Microbes and Infection, 2006
View PDFchevron_right
Current Advances in the Development of Drug and Vaccine for Tuberculosis Prevention and Treatment
GEBIRU Wondie
Eurasian Journal of Medical Investigation, 2020
View PDFchevron_right